Cancer Family
Breast Neoplasm
CI-CAN-00000007Explore in graph →
Non-malignant2,895 active trials43 approved drugs310 evidence items
- NCIt
- C2910
- OncoTree
- BNNOS
- MeSH
- D000069584
- MeSH
- D001943
Loading cancer entity…
Cancer Family
CI-CAN-00000007Explore in graph →
Clinical trials
13,871 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT07163481 | A Trial to Evaluate Sacituzumab Govitecan in Combination With Endocrine Therapy in Patients With HR-positive, HER2-negative Metastatic Breast Cancer Progressed on CDK4/6 Inhibitors(SoGreat) | not yet recruiting | Phase 1 | 12 | Hunan Cancer HospitalOTHER | 1 | Sep 16, 2025 | clinicaltrials |
| NCT07173556 | A Phase Ib/II Study of QLC1401 Combined With CDK4/6 or mTOR Inhibitors in ER+/HER2- Advanced Breast Cancer | not yet recruiting | Phase 1 / Phase 2 | 96 | Qilu Pharmaceutical Co., Ltd.INDUSTRY |
| 0 |
| Sep 15, 2025 |
| clinicaltrials |
| NCT07169864 | Simple Surgical Glove Compression to Prevent Chemotherapy-Induced Peripheral Neuropathy | not yet recruiting | N/A | 44 | Jinsong LuOTHER | 1 | Sep 12, 2025 | clinicaltrials |
| NCT07169539 | Digital Tool for Psychological Support in Women With Breast Cancer(SerenApp) | not yet recruiting | N/A | 90 | Hospital Costa del SolOTHER | 1 | Sep 11, 2025 | clinicaltrials |
| NCT07130344 | PERCIST Evaluation of Trastuzumab Deruxtecan in the Treatment of HER2 Low Breast Cancer(PERPETUAL) | not yet recruiting | N/A | 262 | Centre Paul StraussOTHER | 1 | Sep 10, 2025 | clinicaltrials |
| NCT07164872 | Neoadjuvant Chemotherapy Combined With Preoperative Radiotherapy for Locally Advanced Breast Cancer | not yet recruiting | N/A | 50 | Cancer Institute and Hospital, Chinese Academy of Medical SciencesOTHER | 0 | Sep 10, 2025 | clinicaltrials |
| NCT05806385 | Grouping Immune-modulation With Cryoablation (LOGIC) for Breast Cancers(LOGIC) | not yet recruiting | Phase 1 / Phase 2 | 36 | Texas Tech University Health Sciences CenterOTHER | 0 | Sep 9, 2025 | clinicaltrials |
| NCT07161791 | Camrelizumab, Pirfenidone, and Chemotherapy in the Treatment of Advanced Triple-Negative Breast Cancer | not yet recruiting | Phase 1 / Phase 2 | 12 | Harbin Medical UniversityOTHER | 0 | Sep 9, 2025 | clinicaltrials |
| NCT07162259 | Cohort Study on Sequential ADC Therapy in HR-positive/HER2-negative Advanced Breast Cancer | not yet recruiting | Phase 4 | 40 | Yan XueOTHER | 1 | Sep 9, 2025 | clinicaltrials |
| NCT07162519 | Romiplostim N01 in the Treatment of Thrombocytopenia Caused by Cytotoxic Drugs in Breast Cancer Patients | not yet recruiting | N/A | 68 | Tianjin Medical University Cancer Institute and HospitalOTHER | 0 | Sep 9, 2025 | clinicaltrials |
| NCT05871437 | Randomized Controlled Clinical Study on the Reduction of Tumor Marker Levels in Breast Cancer Patients by Huaier Granules | not yet recruiting | Phase 4 | 232 | Fudan UniversityOTHER | 1 | Sep 8, 2025 | clinicaltrials |
| NCT07040644 | A Study of Sacituzumab Govitecan Plus Toripalimab Versus Toripalimab Plus Nab-Paclitaxel in PD-L1 Positive Advanced TNBC | not yet recruiting | Phase 2 | 150 | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityOTHER | 1 | Sep 8, 2025 | clinicaltrials |
| NCT07160010 | Clinical Validation of Sophia Genetics Assay(COSMOS) | not yet recruiting | — | 248 | Fondazione Policlinico Universitario Agostino Gemelli IRCCSOTHER | 0 | Sep 8, 2025 | clinicaltrials |
| NCT07153965 | Sacituzumab Tirumotecan Plus Tagitanlimab in Previously Treated Locally Advanced or Metastatic Triple Negative Breast Cancer | not yet recruiting | Phase 2 | 47 | Tianjin Medical University Cancer Institute and HospitalOTHER | 1 | Sep 4, 2025 | clinicaltrials |
| NCT07146009 | Targeted Nerve Surgery for the Prevention of Post-Mastectomy Pain Syndrome: A Randomized Trial | not yet recruiting | N/A | 60 | Advanced Reconstructive Surgery AllianceOTHER_GOV | 0 | Aug 28, 2025 | clinicaltrials |
| NCT07129187 | SHR-A1811 for HER2-positive Breast Cancer With Suboptimal Neoadjuvant Response | not yet recruiting | Phase 2 | 30 | Chuan WangOTHER | 0 | Aug 26, 2025 | clinicaltrials |
| NCT07139470 | Sacituzumab Tirumotecan Plus Anlotinib for Metastatic Triple Negative Breast Cancer | not yet recruiting | Phase 1 / Phase 2 | 59 | Tianjin Medical University Cancer Institute and HospitalOTHER | 1 | Aug 24, 2025 | clinicaltrials |
| NCT07136974 | Efficacy of TQB2102 Versus TCbHP in Neoadjuvant Therapy for HER2-positive Early Breast Cancer. | not yet recruiting | Phase 2 | 280 | Henan Cancer HospitalOTHER_GOV | 1 | Aug 22, 2025 | clinicaltrials |
| NCT07133685 | Evaluation of Serum IL-7 as a Biomarker in Breast Cancer | not yet recruiting | — | 140 | Assiut UniversityOTHER | 0 | Aug 21, 2025 | clinicaltrials |
| NCT07132242 | SHR-A1811 Combine With Pyrotinib for Locally Advanced/Metastatic HER2 Positive Breast Cancer | not yet recruiting | Phase 2 | 84 | Cancer Institute and Hospital, Chinese Academy of Medical SciencesOTHER | 0 | Aug 20, 2025 | clinicaltrials |
| NCT07132502 | Treatment Intermittent Periods Based on ctDNA-MRD(Circulating Tumor DNA-minimal Residual Disease) Status in Advanced HER2-Positive Breast Cancer | not yet recruiting | — | 24 | Cancer Institute and Hospital, Chinese Academy of Medical SciencesOTHER | 0 | Aug 20, 2025 | clinicaltrials |
| NCT07130162 | Phosphatidylinositol Glycan Anchor Biosynthesis Class U Protein in Breast Cancer | not yet recruiting | — | 96 | Assiut UniversityOTHER | 0 | Aug 19, 2025 | clinicaltrials |
| NCT07107217 | Camrelizumab in Combination With Chemotherapy as Neoadjuvant Treatment in Patients With Early or Locally Advanced Triple-negative Breast Cancer(Camella) | not yet recruiting | Phase 2 | 40 | Blokhin's Russian Cancer Research CenterOTHER | 0 | Aug 17, 2025 | clinicaltrials |
| NCT07125950 | SHR2554 Combined With Endocrine Therapy in Advanced Breast Cancer | not yet recruiting | Phase 2 | 60 | Henan Cancer HospitalOTHER_GOV | 1 | Aug 15, 2025 | clinicaltrials |
| NCT07116824 | HB1801 Combined Treatment of HER2-positive Breast Cancer | not yet recruiting | Phase 2 | 80 | CSPC ZhongQi Pharmaceutical Technology Co., Ltd.INDUSTRY | 0 | Aug 12, 2025 | clinicaltrials |
| NCT07114679 | Molecular Breast Imaging (MBI)-Guided Biopsy(MBI-GB-Pilot) | not yet recruiting | N/A | 250 | Smart Breast Corp.INDUSTRY | 1 | Aug 11, 2025 | clinicaltrials |
| NCT07113418 | Role of FGF21 in Breast Cancer | not yet recruiting | — | 84 | Assiut UniversityOTHER | 1 | Aug 8, 2025 | clinicaltrials |
| NCT06973525 | This Study Aims to Optimize Neoadjuvant Therapy for HER2-positive Breast Cancer by Implementing a Dynamic Monitoring-guided Treatment Strategy.(HER2-DM-NACT) | not yet recruiting | Phase 2 | 30 | Hebei Medical University Fourth HospitalOTHER | 0 | Aug 5, 2025 | clinicaltrials |
| NCT07098507 | De-escalation in Axillary Surgery for Early-stage Breast Cancer(RIDES) | not yet recruiting | N/A | 620 | Clinical Hospital Center RijekaOTHER | 1 | Aug 1, 2025 | clinicaltrials |
| NCT07000396 | The Role of Mucosal Associated Invariant t Lymphocytes in Breast Cancer | not yet recruiting | — | 74 | Assiut UniversityOTHER | 0 | Jul 30, 2025 | clinicaltrials |
| NCT07093775 | Additional Prognostic Value of Tumor Grade Beyond the 21-gene Recurrence Score | not yet recruiting | — | 4,000 | Gangnam Severance HospitalOTHER | 0 | Jul 30, 2025 | clinicaltrials |
| NCT07093931 | Efficacy and Safety of Lobaplatin and Carboplatin as Neoadjuvant Therapy in HER-2 Positive Breast Cancer | not yet recruiting | Phase 4 | 468 | Shandong Cancer Hospital and InstituteOTHER | 1 | Jul 30, 2025 | clinicaltrials |
| NCT07007780 | Sacituzumab Tirumotecan in Neoadjuvant Treatment of Early-Stage TNBC | not yet recruiting | Phase 2 | 35 | Xijing HospitalOTHER | 0 | Jul 29, 2025 | clinicaltrials |
| NCT07088588 | Study of SYN608 for the Treatment of Advanced or Metastatic Solid Tumors | not yet recruiting | Phase 1 | 105 | Hangzhou SynRx Therapeutics Biomedical Technology Co., LtdINDUSTRY | 1 | Jul 28, 2025 | clinicaltrials |
| NCT07083310 | The Effect of Health Education Conducted Using Two Different Methods on Women's Knowledge of Breast Cancer, Health Beliefs, Mammography Self-Efficacy, and Participation in Screening Programs | not yet recruiting | N/A | 78 | Saglik Bilimleri Universitesi Gulhane Tip FakultesiOTHER | 0 | Jul 24, 2025 | clinicaltrials |
| NCT07083505 | A Study Comparing the Efficacy and Safety of HB1801 With Taxotere® in Advanced Breast Cancer | not yet recruiting | Phase 2 | 60 | CSPC ZhongQi Pharmaceutical Technology Co., Ltd.INDUSTRY | 0 | Jul 24, 2025 | clinicaltrials |
| NCT07077018 | Fasting-Mimicking Diet as an Adjunct to Neoadjuvant Chemotherapy for Hormone-Receptor-Positive Breast Cancer | not yet recruiting | N/A | 45 | Guangdong Provincial People's HospitalOTHER | 1 | Jul 22, 2025 | clinicaltrials |
| NCT07034248 | Electrochemical Biosensor Based on Lectin-functionalized Nitrogen, Sulfur-doped Graphene Quantum Dot Decorated Gold Nanoparticles for Breast Cancer Diagnosis: From Academic Research to Clinical Translation | not yet recruiting | — | 240 | Chang Gung Memorial HospitalOTHER | 0 | Jul 18, 2025 | clinicaltrials |
| NCT03978780 | Erector Spinae Block vs. Placebo Block Study | not yet recruiting | N/A | 60 | Women's College HospitalOTHER | 1 | Jul 16, 2025 | clinicaltrials |
| NCT07067307 | Melatonin in Breast Cancer Patients Receiving Neoadjuvant Chemotherapy | not yet recruiting | Phase 1 / Phase 2 | 80 | Mansoura UniversityOTHER | 1 | Jul 16, 2025 | clinicaltrials |
| NCT07063667 | Artificial Intelligence Model-Assisted Accurate Diagnosis of Early-Stage Breast Cancer | not yet recruiting | — | 900 | Daping Hospital and the Research Institute of Surgery of the Third Military Medical UniversityOTHER | 1 | Jul 14, 2025 | clinicaltrials |
| NCT06835400 | Oral Paclitaxel + Encequidar vs IV Paclitaxel in Treatment of HER2 Negative Metastatic Breast Cancer | not yet recruiting | Phase 3 | 340 | Health Hope PharmaINDUSTRY | 0 | Jul 11, 2025 | clinicaltrials |
| NCT07047443 | SHR-1811 Combined With Carboplatin in the Treatment of Advanced Breast Cancer With HER2 Expression | not yet recruiting | Phase 2 | 18 | Anhui Provincial Cancer HospitalOTHER | 1 | Jul 2, 2025 | clinicaltrials |
| NCT07047755 | Trastuzumab Rezetecan Plus Pertuzumab in the Neoadjuvant Treatment of HER2 Positive BC | not yet recruiting | Phase 2 | 48 | Henan Cancer HospitalOTHER_GOV | 0 | Jul 2, 2025 | clinicaltrials |
| NCT07042737 | The Effect of Animation-Based Education on Menopausal Women's Attitudes, Behaviors, and Screening Test Participation Regarding Breast Cancer(Menopause) | not yet recruiting | N/A | 136 | Inonu UniversityOTHER | 1 | Jun 29, 2025 | clinicaltrials |
| NCT07041437 | Study of SHR-A2102 Combined Other Antitumor Drugs in Advanced Breast Cancer | not yet recruiting | Phase 2 | 48 | Fudan UniversityOTHER | 1 | Jun 27, 2025 | clinicaltrials |
| NCT07036185 | A Clinical Trail of KJ015 in Patients With HER2-Expressing Solid Tumors | not yet recruiting | Phase 1 | 66 | Shanghai Bao Pharmaceuticals Co., Ltd.INDUSTRY | 1 | Jun 25, 2025 | clinicaltrials |
| NCT07032883 | Benson Relaxation Technique Effectiveness on Pain and Quality of Life Post Reconstructive Mammoplasty | not yet recruiting | N/A | 68 | Cairo UniversityOTHER | 1 | Jun 24, 2025 | clinicaltrials |
| NCT06434077 | Clinical Trial Protocol: Randomized Placebo-Controlled Pilot Study of GcMAF (Soloways TM) in Patients With Metastatic Breast Cancer | not yet recruiting | Phase 3 | 60 | S.LAB (SOLOWAYS)OTHER | 1 | Jun 22, 2025 | clinicaltrials |
| NCT07029646 | Comparative Research on the Accuracy of Margin Interpretation in Breast-Conserving Surgery for Breast Cancer: Cell Microscopic Imaging and Standard Frozen Pathology | not yet recruiting | N/A | 167 | Peking University Cancer Hospital & InstituteOTHER | 0 | Jun 19, 2025 | clinicaltrials |
Data updated 23 days agoSource updated Sep 16, 2025source: clinicaltrials